| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.4B | $7.8B | $7.9B | $7.1B | $5.1B | $1.3B | $1.3B | $1.5B |
| Cost of Revenue | $6.0B | $6.3B | $6.3B | $5.6B | $4.0B | $3.9B | $4.8B | $4.5B |
| Gross Profit | $1.5B | $1.5B | $1.6B | $1.5B | $1.1B | $0.2B | $0.2B | $0.3B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.0B | $1.0B | $1.0B | $0.9B | $0.7B | $0.7B | $0.8B | $0.7B |
| Operating Income | $0.4B | $0.5B | $0.5B | $0.5B | $0.3B | $0.1B | $0.0B | $0.1B |
| Net Income | $0.3B | $0.3B | $0.3B | $0.4B | $0.2B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $3.37 | $3.85 | $4.28 | $7.06 | $4.32 | $0.74 | $0.65 | $1.22 |
| EPS (Diluted) | $3.27 | $3.72 | $4.15 | $6.85 | $4.17 | $0.72 | $0.64 | $1.20 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.4B | $4.6B | $4.4B | $3.8B | $3.1B | $3.0B | $3.4B | $3.2B |
| Current Assets | $2.1B | $2.4B | $2.3B | $1.9B | $1.3B | $1.4B | $1.7B | $1.7B |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.3B | $0.2B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.5B | $1.7B | $1.7B | $1.4B | $1.0B | $1.0B | $1.5B | $1.5B |
| Stockholders' Equity | $2.2B | $2.1B | $1.9B | $1.7B | $1.5B | $1.3B | $1.2B | $1.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.6B | $0.3B | $0.3B | $0.4B | $0.8B | $0.4B | $0.2B |
| Investing Cash Flow | $-0.4B | $-0.4B | $-0.4B | $-0.2B | $-0.4B | $-0.1B | $-0.3B | $-0.2B |
| Capital Expenditures | $0.4B | $0.4B | $0.4B | $0.2B | $0.2B | $0.1B | $0.3B | $0.2B |
| Financing Cash Flow | $-0.5B | $-0.1B | $0.1B | $-0.0B | $-0.2B | $-0.5B | $-0.1B | $0.0B |